Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
Early Hum Dev ; 194: 106050, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38781715

ABSTRACT

BACKGROUND: Our objective was to determine whether the use of two or more courses of low-dose systemic dexamethasone for extubation of ventilator-dependent preterm infants after the first week of life, as proposed in the DART study, is associated with greater neurodevelopmental harm at two years of corrected age, compared to a single course. METHODS: Retrospective review at seven level III neonatal intensive care units. Preterm infants who underwent only one course of systemic dexamethasone for extubation were grouped into DART-1; those who underwent two or more courses were grouped into DART-2. Data and outcomes of infants in DART-2 were compared with those in DART-1. RESULTS: 150 preterm infants were studied: 104 in DART-1 and 46 in DART-2. Patients in DART-2 had a lower gestational age (25 vs. 26 weeks, p = 0.031) and greater morbidity. The average dexamethasone cumulative dose for patients in DART-1 was 0.819 mg/kg, vs. 1.697 mg/kg for patients in DART-2. A total of 14 patients died. The neuromotor and neurosensory assessments at two years of corrected age revealed in the DART-2 survivors, after the multivariate analysis, a higher prevalence of cerebral palsy with functional motor class 2 (OR = 6.837; 95%CI: 1.054-44.337; p = 0.044) and ophthalmological problems requiring the use of glasses (OR = 4.157; 95%CI: 1.026-16.837; p = 0.046). CONCLUSIONS: In this cohort, the use of more than one course of systemic dexamethasone in low doses for extubation of ventilator-dependent premature infants after the first week of life was associated, at two years of corrected age, with a higher prevalence of cerebral palsy with functional motor class 2 and ophthalmological problems requiring the use of glasses.


Subject(s)
Cerebral Palsy , Dexamethasone , Infant, Premature , Humans , Dexamethasone/administration & dosage , Dexamethasone/adverse effects , Cerebral Palsy/epidemiology , Infant, Newborn , Female , Male , Retrospective Studies , Child, Preschool , Prevalence , Airway Extubation , Respiration, Artificial
12.
J Appl Oral Sci ; 27: e20180103, 2019.
Article in English | MEDLINE | ID: mdl-30994771

ABSTRACT

OBJECTIVE: This study aimed to evaluate the inflammatory effect and bone formation in sterile surgical failures after implantation of a collagen sponge with mesenchymal stem cells from human dental pulp (hDPSCs) and Aloe vera. MATERIAL AND METHODS: Rattus norvegicus (n=75) were divided into five experimental groups according to treatment: G1) control (blood clot); G2) Hemospon®; G3) Hemospon® in a culture medium enriched with 8% Aloe vera; G4) Hemospon® in a culture medium containing hDPSCs and G5) Hemospon® in a culture medium enriched with 8% Aloe vera and hDPSCs. On days 7, 15 and 30, the animals were euthanized, and the tibia was dissected for histological, immunohistochemistry and immunofluorescence analyses. The results were analyzed using nonparametric Kruskal-Wallis test and Dunn's post-test. RESULTS: On days 7 and 15, the groups with Aloe vera had less average acute inflammatory infiltrate compared to the control group and the group with Hemospon® (p<0.05). No statistically significant difference was found between the groups regarding bone formation at the three experimental points in time. Osteopontin expression corroborated the intensity of bone formation. Fluorescence microscopy revealed positive labeling with Q-Tracker® in hDPSCs before transplantation and tissue repair. CONCLUSION: The results suggest that the combination of Hemospon®, Aloe vera and hDPSCs is a form of clinical treatment for the repair of non-critical bone defects that reduces the inflammatory cascade's effects.


Subject(s)
Aloe/chemistry , Bone Regeneration/drug effects , Bone Regeneration/physiology , Dental Pulp/cytology , Mesenchymal Stem Cell Transplantation/methods , Plant Extracts/pharmacology , Animals , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Collagen/pharmacology , Flow Cytometry , Hemostatics/pharmacology , Humans , Immunohistochemistry , Male , Microscopy, Fluorescence , Osteogenesis/drug effects , Osteogenesis/physiology , Osteopontin/analysis , Rats , Reproducibility of Results , Tibia/drug effects , Tibia/pathology , Tibia/physiology , Time Factors , Treatment Outcome
14.
J. appl. oral sci ; 27: e20180103, 2019. graf
Article in English | LILACS, BBO - Dentistry | ID: biblio-1002400

ABSTRACT

Abstract Objective This study aimed to evaluate the inflammatory effect and bone formation in sterile surgical failures after implantation of a collagen sponge with mesenchymal stem cells from human dental pulp (hDPSCs) and Aloe vera. Material and Methods Rattus norvegicus (n=75) were divided into five experimental groups according to treatment: G1) control (blood clot); G2) Hemospon®; G3) Hemospon® in a culture medium enriched with 8% Aloe vera; G4) Hemospon® in a culture medium containing hDPSCs and G5) Hemospon® in a culture medium enriched with 8% Aloe vera and hDPSCs. On days 7, 15 and 30, the animals were euthanized, and the tibia was dissected for histological, immunohistochemistry and immunofluorescence analyses. The results were analyzed using nonparametric Kruskal-Wallis test and Dunn's post-test. Results On days 7 and 15, the groups with Aloe vera had less average acute inflammatory infiltrate compared to the control group and the group with Hemospon® (p<0.05). No statistically significant difference was found between the groups regarding bone formation at the three experimental points in time. Osteopontin expression corroborated the intensity of bone formation. Fluorescence microscopy revealed positive labeling with Q-Tracker® in hDPSCs before transplantation and tissue repair. Conclusion The results suggest that the combination of Hemospon®, Aloe vera and hDPSCs is a form of clinical treatment for the repair of non-critical bone defects that reduces the inflammatory cascade's effects.


Subject(s)
Humans , Animals , Male , Rats , Bone Regeneration/drug effects , Bone Regeneration/physiology , Plant Extracts/pharmacology , Dental Pulp/cytology , Mesenchymal Stem Cell Transplantation/methods , Aloe/chemistry , Osteogenesis/drug effects , Osteogenesis/physiology , Tibia/drug effects , Tibia/physiology , Tibia/pathology , Time Factors , Immunohistochemistry , Hemostatics/pharmacology , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Reproducibility of Results , Collagen/pharmacology , Treatment Outcome , Osteopontin/analysis , Flow Cytometry , Microscopy, Fluorescence
17.
Rev. odontol. UNESP (Online) ; 47(2): 98-105, Mar.-Apr. 2018. tab, ilus
Article in Portuguese | LILACS, BBO - Dentistry | ID: biblio-902704

ABSTRACT

Introdução : O hidróxido de cálcio é considerado uma medicação intracanal padrão ouro e diferentes substâncias podem ser empregadas como veículo para melhorar suas propriedades. O Aloe vera é um fitoterápico popularmente conhecido por babosa e que se destaca pela sua capacidade imunorreguladora, antimicrobiana, cicatrizante e pela biocompatibilidade celular. Objetivo: Avaliar a dissociação iônica do hidróxido de cálcio, tendo o Aloe vera como veículo. Material e método: O extrato de Aloe vera foi obtido diretamente da folha, submetido à filtração e armazenado em tubo Falcon estéril. Foram preparados dois grupos de medicação intracanal: o grupo controle, com hidróxido de cálcio e soro fisiológico, e o grupo experimental, com hidróxido de cálcio e Aloe vera como veículo. Resultado: Não foi verificada uma diferença estatisticamente significativa entre as médias de liberação de cálcio dos grupos (p=0,944). Quando comparados os valores de forma pareada, considerando as diferentes avaliações ao longo do tempo, foi identificada uma diferença estatisticamente significativa (p=0,015) para o grupo experimental, de modo que os valores médios da liberação de cálcio foram superiores até o 21º dia do estudo. Conclusão: O hidróxido de cálcio, quando associado ao Aloe vera, apresentou maior dissociação iônica que quando utilizado com água destilada. Tal resultado, associado às propriedades inerentes deste fitoterápico, sugerem que a pasta de hidróxido de cálcio e Aloe vera pode ser uma alternativa viável e promissora como medicação intracanal, e melhorar o reparo apical e periapical.


Introduction: Calcium hydroxide is considered an intracanal medication gold standard, and different substances can be employed as a vehicle to improve its properties. Aloe vera is a herbal remedy popularly known as babosa and is notable for its immunoregulatory, antimicrobial, healing and cellular biocompatibility. Objective: To evaluate the ionic dissociation of calcium hydroxide, with the Aloe vera as vehicle. Material and method: The extract of Aloe vera was obtained directly from the leaf, submitted to filtration and stored in a sterile falcon tube. Two groups of intracanal medication were prepared; the control group, with calcium hydroxide and saline; and the experimental group, with calcium hydroxide and Aloe vera as vehicle. Result: There was no statistically significant difference between the means of calcium release from the groups (p = 0.944). When comparing the paired values, considering the different evaluations over time, a statistically significant difference (p = 0.015) was identified for the experimental group, so that mean values of calcium released were higher up to the 21st day of the study. Conclusion: Calcium hydroxide, when associated with Aloe vera, presented higher ionic dissociation than when used with distilled water. This result, combined with the inherent properties of this herbal remedy, suggests that the paste of calcium hydroxide and Aloe vera can be a viable and promising alternative as intracanal medication and improve apical and periapical repair.


Subject(s)
Calcium Hydroxide , Distilled Water , Endodontics , Aloe , Phytotherapeutic Drugs
18.
Case Rep Endocrinol ; 2018: 9564737, 2018.
Article in English | MEDLINE | ID: mdl-30662777

ABSTRACT

Fetal goiter is a rare disorder not expected to be found during a healthy woman's pregnancy. It can be a prenatal manifestation of congenital hypothyroidism due to thyroid dyshormonogenesis and it can lead to serious perinatal complications. A vascularized fetal neck mass was detected at 29 weeks' gestation of a healthy primigravida. Magnetic resonance was suggestive of goiter causing airway deviation without polyhydramnios. Maternal thyroid function was normal and thyroid antibodies were negative. Two intra-amniotic levothyroxine infusions were performed at 32 and 33 weeks. Serial imaging control showed no progression of the mass. Elective caesarean section was performed at 38 weeks. The male newborn was admitted to the intensive care unit due to cardiorespiratory insufficiency with pulmonary hypertension. Hormonal assays revealed primary congenital hypothyroidism and ultrasonography confirmed diffuse goiter. Levothyroxine was started. Currently, he is 6 years old with adequate growth and normal psychomotor development. Genetic study found a heterozygous mutation in the TPO gene.

19.
Dis Markers ; 2016: 8293196, 2016.
Article in English | MEDLINE | ID: mdl-27313335

ABSTRACT

VEGF and podoplanin (PDPN) have been identified as angiogenesis and/or lymphangiogenesis regulators and might be essential to restrict tumor growth, progression, and metastasis. In the present study, we evaluate the association between the expression of these markers and CIN grade. Immunohistochemistry was performed in 234 uterine cervical samples using conventional histologic sections or TMA with the monoclonal antibodies to VEGF (C-1 clone) and podoplanin (D2-40 clone). Positive-staining rates of VEGF in 191 CIN specimens were significantly associated with histological grade (P < 0.001). Negative and/or focal immunostaining for PDPN were more frequent in CIN 3 (P = 0.016). We found that patients with CIN 3 more frequently had strong and more diffuse staining for VEGF and diminished staining for PDPN (P = 0.018). Strong and more diffuse VEGF immunoexpressions in CIN 2 and CIN 3 were detected when compared to CIN 1. Negative and/or focal PDPN immunoexpression appear to be more frequent in CIN 3. Moderate to strong VEGF expression may be a tendency among patients with high-grade lesions and diminished PDPN expression.


Subject(s)
Biomarkers, Tumor/metabolism , Membrane Glycoproteins/metabolism , Squamous Intraepithelial Lesions of the Cervix/pathology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Neoplasms/pathology , Vascular Endothelial Growth Factor A/metabolism , Adult , Case-Control Studies , Cross-Sectional Studies , Female , Follow-Up Studies , Humans , Immunoenzyme Techniques , Neoplasm Staging , Prognosis , Retrospective Studies , Squamous Intraepithelial Lesions of the Cervix/metabolism , Uterine Cervical Neoplasms/metabolism , Uterine Cervical Dysplasia/metabolism
20.
Pediatr Rep ; 7(2): 5955, 2015 May 25.
Article in English | MEDLINE | ID: mdl-26266034

ABSTRACT

Noonan syndrome is a relatively common and heterogeneous genetic disorder, associated with congenital heart defect in about 50% of the cases. If the defect is not severe, life expectancy is normal. We report a case of Noonan syndrome in a preterm infant with hypertrophic cardiomyopathy and lethal outcome associated to acute respiratory distress syndrome caused by Adenovirus pneumonia. A novel mutation in the RAF1 gene was identified: c.782C>G (p.Pro261Arg) in heterozygosity, not described previously in the literature. Consequently, the common clinical course in this mutation and its respective contribution to the early fatal outcome is unknown. No conclusion can be established regarding genotype/phenotype correlation.

SELECTION OF CITATIONS
SEARCH DETAIL
...